bladder cancer - search results

Danish researchers have discovered new molecular sub-groups in early stages of bladder cancer.

Colorado Cancer Center's whole-exome sequencing of most-used cancer cell lines detail genetic alterations that may aid in therapy selection.

Patient-derived tumor organoids--3D tissue cultures derived from tumor tissue samples--could be used to predict the most suitable treatment for patients with biliary tract cancer, suggests research presented at Digestive Disease Week 2023 in Chicago.

People who undergo bariatric surgery have less than half the risk for developing an obesity-associated cancer than their peers who do not receive weight loss surgery.

The FDA just granted Seagen's PADCEV and Merck's KEYTRUDA accelerated approval as a combination therapy for advanced urothelial cancer.

European cancer mortality predictions for 2023 suggest death rates will be 6.5% lower in men and 3.7% lower in women than they were in 2018.

Natera announced today that it received written confirmation from the Centers for Medicare & Medicaid Services (CMS) that its Signatera molecular residual disease (MRD) test will be reimbursed for adjuvant and recurrence monitoring in patients with stage IIb or higher breast cancer.

HALO Diagnostics and breast imaging company Ikonopedia have inked a genetic testing partnership to improve breast cancer detection and outcomes.

The research team focused on natural killer (NK) cells, and developed a monoclonal antibody to block a protein, KIR2DL5, on NK cells.

Invitae’s Ciitizen genomic and health history data will be used in a retrospective and prospective study of patients diagnosed with the rare bile duct cancer cholangiocarcinoma.